Defence Finance Monitor

Defence Finance Monitor

TreeFrog Therapeutics: Scaling Regenerative Medicine for European Strategic Autonomy

Dec 28, 2025
∙ Paid

TreeFrog Therapeutics is a French biotech innovator developing industrial-scale platforms to produce stem cells for regenerative medicine. Its core C-Stem technology uses microfluidic encapsulation to grow 3D stem-cell microtissues at unprecedented scale[1][2]. For example, in 2021 TreeFrog reported a record batch of 15 billion pluripotent stem cells gr…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Defence Finance Monitor · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture